Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Synta Pharmaceuticals Corp.
ClinicalTrials.gov Identifier:
NCT00522834
First received: August 28, 2007
Last updated: January 31, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 31, 2014